(Q70162161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

S H Lim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

C Worman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A Jewell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

C Tsakona

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

F J Giles

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

A Goldstone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

133-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01742542

9 October 2019

exact match

0 references

1 reference

12 December 2020

Malignant chronic lymphocytic leukemia B cells elaborate soluble factors that down-regulate T cell and NK function

1 reference

12 December 2020

Immunological reactivity and bioactivity of tumour necrosis factor

1 reference

12 December 2020

Production of tumour-derived suppressor factor in patients with acute myeloid leukaemia

1 reference

12 December 2020

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

12 December 2020

Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells

1 reference

12 December 2020

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

1 reference

12 December 2020

A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Soluble CD8 during T cell activation

1 reference

12 December 2020

Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors

1 reference

12 December 2020

Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy

1 reference

12 December 2020

Serine esterase in cytolytic T lymphocytes

1 reference

12 December 2020

Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase

1 reference

12 December 2020

The released interleukin 2 receptor binds interleukin 2 efficiently

1 reference

12 December 2020

The requirement for proteinase activity for human lymphocyte-mediated natural cytotoxicity (NK): evidence that the proteinase is serine dependent and has aromatic amino acid specificity of cleavage

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01742542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2036661%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference